Lobbying

Margo RX's latest lobbying report covers Q1 2026, at under $5,000. Its first report covers Q1 2022; the issues it reports most are Pharmacy.

Margo RX

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q1 2022
The first quarter a report named it

Lobbying by quarter

No lobbying spend in this period.

Margo RX lobbying by quarter
Margo RX lobbying by quarter
QuarterAmountReports
Q1 2022$01
Q2 2022$01
Q3 2022$01
Q4 2022$00
Q1 2023$01
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$01
Q3 2025$01
Q4 2025$01
Q1 2026$01
Q2 2026$00
Q3 2026$00

By issue

  • Pharmacy$0 · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health & Human Services, Dept of (HHS)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE1 reports

Firms it paid

Firm
MR. H.R. Bert Pena$016 quarters

Former officials lobbying for it

Former position
HR BERT PENAFormer Staff Director to House Committee on AgQ4 2025

Lobbying reports

Filed by
06/01for Q1MR. H.R. Bert PenaUnder $5,000
01/12for Q4 2025MR. H.R. Bert PenaUnder $5,000
25/12/16for Q3 2025MR. H.R. Bert PenaUnder $5,000
25/07/10for Q2 2025MR. H.R. Bert PenaUnder $5,000
25/04/11for Q1 2025MR. H.R. Bert PenaUnder $5,000
25/02/04for Q4 2024MR. H.R. Bert PenaUnder $5,000
24/11/07for Q3 2024MR. H.R. Bert PenaUnder $5,000
24/10/10for Q3 2024MR. H.R. Bert PenaUnder $5,000
24/07/11for Q2 2024MR. H.R. Bert PenaUnder $5,000
24/05/02for Q1 2024MR. H.R. Bert PenaUnder $5,000
24/01/10for Q4 2023MR. H.R. Bert PenaUnder $5,000
23/10/06for Q3 2023MR. H.R. Bert PenaUnder $5,000
23/07/11for Q2 2023MR. H.R. Bert PenaUnder $5,000
23/05/26for Q1 2023MR. H.R. Bert PenaUnder $5,000
23/05/26for Q3 2022MR. H.R. Bert PenaUnder $5,000
23/05/26for Q3 2022MR. H.R. Bert PenaUnder $5,000
23/05/26for Q2 2022MR. H.R. Bert PenaUnder $5,000
23/05/26for Q1 2022MR. H.R. Bert PenaUnder $5,000